Behavioral and neurochemical effects of wild-type and mutated human α-synuclein in transgenic mice

Experimental Neurology

Volumn 175, Issue 1, 2002, Pages 35-48

  Richfield, Eric K ^a   Thiruchelvam, Mona J ^a   Cory Slechta, Deborah A ^a   Wuertzer, Charles ^a   Gainetdinov, Raul R ^b   Caron, Marc G ^b   Di Monte, Donato A ^c   Federoff, Howard J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c PARKINSON S INSTITUTE   (United States)

Author keywords

Dopamine; MPTP; Nigrostriatal system; Parkinson's disease; Substantia nigra; Transgenic mice; synuclein

Indexed keywords

ALPHA SYNUCLEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; MOTOR COORDINATION; MOUSE; NEUROCHEMISTRY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; SUBSTANTIA NIGRA; TRANSGENIC MOUSE;

EID: 0036245056     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2002.7882     Document Type: Article

References (51)

1. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
2. Extensive axonal Lewy neurites in Parkinson's disease: A novel pathological feature revealed by alpha-synuclein immunocytochemistry
3. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
4. + elimination in the mouse striatum
5. Genetic polymorphisms in Parkinson's disease
6. Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas
7. Synucleins in synaptic plasticity and neurodegenerative disorders
8. A new device for the rapid measurement of impaired motor function in mice
9. Cocaine reward and MPTP toxicity: Alteration by regional variant dopamine transporter overexpression
10. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions
11. A strain-specific modifier on mouse chromosome 4 controls the methylation of independent transgene loci
12. A Drosophila model of Parkinson's disease
13. α-synuclein and Parkinson's disease: Selective neurodegenerative effects of α-synuclein fragment on dopaminergic neurons in vivo and in vitro
14. Dopamine transporter is required for in vivo MPTP neurotoxicity: Evidence from mice lacking the transporter
15. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains α-, β-, and γ-synuclein
16. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions
17. Differential strain suscedptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosmal dominant fashion: Quantitative analysis in seven strains of Mus musculus
18. Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasi of ectopic cells
19. The cDNA cloning and ontogency of mouse α-synuclein
20. Overview of morphological changes in Parkinson's disease
21. Parkinson's disease is not associated with the combined α-synuclein/apolipoprotein E susceptibility genotype
22. Somatic transgenic models of tau and α-synuclein protein aggregation in specific subregions of the rodent brain
23. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
24. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype
25. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
26. Direct binding and functional coupling of α-synuclein to the dopamine transporter accelerates dopamine-induced apoptosis
27. Neuronal and behavioral pathology in transgenic mice expressing α-synuclein
28. Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal
29. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders
30. Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter
31. Effects of estrogen treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice
32. AMPA receptors are involved in the expression of amphetmine-induced behavioral sensitization, but not in the expression of amphetamine-induced conditioned activity in mice
33. Dopamine transmporters and neuronal injury
34. 5′ Upstream DNA sequence of the rat tyrosine hydroxylase gene directs high-level and tissue-specific expression to catecholaminergic neurons in the central nervous system of transgenic mice
35. Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons
36. High resolution two-dimensional electrophoresis of proteins
37. Constitutive phosphorylation of the Parkinosn's disease associated α-synuclein
38. The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity
39. Induction of alpha synuclein aggregation by intracellular nitrative insult
40. α-synuclein may be a chaperone for tyrosine hydroxylase
41. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
42. Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant α-synuclein transgenic mice
43. Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake on the dopamine uptake complex
44. Preferential loss of preproenkephalin versus preprotachykinin striatal neurons from Huntington's disease patients
45. Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse α-synuclein
46. The human growth hormone gene family: Nucleotide sequences show recent divergence and predict a new polypeptide hormone
47. Early ontogeny of catecholaminergic cell linearge in brain and peripheral neurons monitored by tyrosine hydroxylase-lacZ transgene
48. alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy-bodies
49. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and Maneb: Implications for Parkinson's disease
50. Neuropathology of mice expressing human α-synuclein
51. Knockout of the vesicular monoamine transporter-2 gene results in neonatal death and supersensitivity to cocaine and amphetamine